Insider Transactions in Q2 2021 at Pmv Pharmaceuticals, Inc. (PMVP)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
David Henry Mack President and CEO |
SELL
Open market or private sale
|
Direct |
204
-1.61%
|
$7,140
$35.53 P/Share
|
|
Jun 28
2021
|
David Henry Mack President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
204
+1.58%
|
$0
$0.53 P/Share
|
|
Jun 21
2021
|
Arnold J Levine |
SELL
Open market or private sale
|
Direct |
3,500
-0.41%
|
$115,500
$33.66 P/Share
|
|
Jun 14
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
44,419
-0.98%
|
$1,510,246
$34.11 P/Share
|
|
Jun 11
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,977
-0.48%
|
$725,241
$33.8 P/Share
|
|
Jun 10
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,633
-0.45%
|
$660,256
$32.68 P/Share
|
|
Jun 09
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
39,638
-0.86%
|
$1,308,054
$33.64 P/Share
|
|
Jun 08
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
31,724
-0.68%
|
$1,046,892
$33.38 P/Share
|
|
Jun 07
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,721
-0.68%
|
$1,013,793
$33.62 P/Share
|
|
Jun 07
2021
|
Leila Alland Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-82.91%
|
$132,000
$33.7 P/Share
|
|
Jun 07
2021
|
Leila Alland Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$12,000
$3.9 P/Share
|
|
Jun 04
2021
|
Winston Kung COO, CFO |
SELL
Open market or private sale
|
Direct |
4,500
-73.77%
|
$148,500
$33.75 P/Share
|
|
Jun 04
2021
|
Winston Kung COO, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+42.45%
|
$13,500
$3.22 P/Share
|
|
Jun 01
2021
|
Richard A. Heyman |
SELL
Open market or private sale
|
Indirect |
3,900
-91.47%
|
$128,700
$33.51 P/Share
|
|
Jun 01
2021
|
Richard A. Heyman |
BUY
Exercise of conversion of derivative security
|
Indirect |
3,900
+50.0%
|
$1,271,400
$326.97 P/Share
|
|
May 28
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
5,100
-0.25%
|
$178,500
$35.8 P/Share
|
|
May 26
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
7,487
-0.37%
|
$262,045
$35.66 P/Share
|
|
May 25
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
8,518
-0.41%
|
$298,130
$35.91 P/Share
|
|
May 24
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
22,095
-1.06%
|
$795,420
$36.03 P/Share
|
|
May 21
2021
|
David Henry Mack President and CEO |
SELL
Open market or private sale
|
Direct |
6,207
-71.53%
|
$217,245
$35.71 P/Share
|
|
May 21
2021
|
David Henry Mack President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,207
+41.7%
|
$0
$0.53 P/Share
|
|
May 21
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
19,774
-0.94%
|
$692,090
$35.84 P/Share
|
|
May 20
2021
|
David Henry Mack President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,793
+43.83%
|
$0
$0.53 P/Share
|
|
May 20
2021
|
David Henry Mack President and CEO |
SELL
Open market or private sale
|
Direct |
7,793
-75.93%
|
$272,755
$35.6 P/Share
|
|
May 20
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
2,911
-0.14%
|
$101,885
$35.65 P/Share
|
|
May 20
2021
|
Arnold J Levine |
SELL
Open market or private sale
|
Direct |
3,500
-0.41%
|
$119,000
$34.13 P/Share
|
|
May 10
2021
|
Interwest Partners X LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
6,446
+31.24%
|
-
|
|
May 10
2021
|
Interwest Partners X LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
5,000
-100.0%
|
-
|
|
May 10
2021
|
Interwest Partners X LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
500,000
-9.14%
|
-
|
|
May 10
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
1,787
-0.08%
|
$62,545
$35.67 P/Share
|
|
May 07
2021
|
Leila Alland Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-98.03%
|
$140,000
$35.15 P/Share
|
|
May 07
2021
|
Leila Alland Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$12,000
$3.9 P/Share
|
|
May 05
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
600
-0.03%
|
$21,000
$35.64 P/Share
|
|
May 03
2021
|
Winston Kung COO, CFO |
SELL
Open market or private sale
|
Direct |
4,500
-73.77%
|
$148,500
$33.75 P/Share
|
|
May 03
2021
|
Winston Kung COO, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+42.45%
|
$13,500
$3.22 P/Share
|
|
Apr 12
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
3,903
-0.06%
|
$124,896
$32.09 P/Share
|
|
Apr 09
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
25,763
-0.6%
|
$875,942
$34.32 P/Share
|
|
Apr 08
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
33,322
-0.77%
|
$1,132,948
$34.03 P/Share
|
|
Apr 07
2021
|
Leila Alland Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-99.65%
|
$136,000
$34.14 P/Share
|
|
Apr 07
2021
|
Leila Alland Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$12,000
$3.9 P/Share
|
|
Apr 07
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
24,457
-0.56%
|
$831,538
$34.19 P/Share
|
|
Apr 06
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
78,657
-1.74%
|
$2,674,338
$34.26 P/Share
|
|
Apr 05
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
48,193
-1.04%
|
$1,590,369
$33.74 P/Share
|
|
Apr 01
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
12,435
-0.53%
|
$397,920
$32.94 P/Share
|